<DOC>
	<DOCNO>NCT00367068</DOCNO>
	<brief_summary>The objective study determine efficacy safety treatment intrathecal baclofen severe spasticity child cerebral palsy .</brief_summary>
	<brief_title>Dutch National ITB Study Children With Cerebral Palsy</brief_title>
	<detailed_description>Spasticity cerebral palsy ( CP ) serious problem lead pain , sleep disturbance , increased expenditure energy and/or interference positioning , transfer , dress body hygiene . In late stage , secondary phenomenon , contracture , decubitus heterotopic calcification joint tendon may create large treatment problem . A substantial group child severe CP respond regular treatment , physical therapy , orthopaedic surgery oral medication . An effective treatment option intractable spasticity continuous delivery intrathecal baclofen ( CITB ) . In 2000 , American Academy Cerebral Palsy Developmental Medicine ( AACPDM ) publish systematic review body evidence intrathecal baclofen ( ITB ) spasticity individual CP . It appear small uncertain number child study . Except two case-reports , none study solely concerned child . The research methodology employ three quarter available study capable confirm treatment effect . The AACPDM underline need high-level research form prospective , randomized trial use valid reliable outcome measure well described homogeneous group . In 1998 Dutch Study Group Child Spasticity design Dutch national study effectiveness safety ITB refractory spasticity child cerebral palsy . The Dutch national ITB study include four phase : 1 ] selection phase , 2 ] double-blind , placebo-controlled dose-escalation test treatment phase , 3 ] prospective , randomize , open-label implantation phase 4 ] follow-up phase .</detailed_description>
	<mesh_term>Paralysis</mesh_term>
	<mesh_term>Cerebral Palsy</mesh_term>
	<mesh_term>Muscle Spasticity</mesh_term>
	<criteria>age 4 16 year spastic diplegia tetraplegia part CP insufficient response oral spasticityreducing medication mixed CP syndrome , spasticity prominent sign spasticity result decrease quality life child and/or caregiver sufficient motivation participation study include availability followup magnetic resonance image brain rule progressive cause spasticity hypersensitivity baclofen contraindication general anaesthesia insufficient general health intractable epileptic seizure infection lumbar skin systemic infection</criteria>
	<gender>All</gender>
	<minimum_age>4 Years</minimum_age>
	<maximum_age>16 Years</maximum_age>
	<verification_date>November 2007</verification_date>
	<keyword>Cerebral palsy</keyword>
	<keyword>Spasticity</keyword>
	<keyword>Child</keyword>
	<keyword>Baclofen</keyword>
	<keyword>Intrathecal injection</keyword>
</DOC>